Design Therapeutics, Inc. DSGN Cash ratio
Cash ratio at other companies
Other financials
Where this comes from
Calculated from Design Therapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Design Therapeutics, Inc.’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Design Therapeutics, Inc.'s cash ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Design Therapeutics, Inc.'s cash ratio?
- Design Therapeutics, Inc. (DSGN) reported cash ratio of 1.3× in Q1 2026.
- How has Design Therapeutics, Inc.'s cash ratio changed year-over-year?
- Design Therapeutics, Inc.'s cash ratio decreased by 24.5% year-over-year, from 1.7× to 1.3×.
- What is the long-term trend for Design Therapeutics, Inc.'s cash ratio?
- Over 5 years (2020 to 2025), Design Therapeutics, Inc.'s cash ratio has grown at a 4.8% compound annual growth rate (CAGR), from 1× to 1.3×.
- What does cash ratio mean?
- Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.